secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001079973-23-001538
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q3 net profit $110K, revenue up 33% to $2.696M; SpinDx beta in early 2024
--------------------------------------------------------------------------------

- Q3 2023 net profit $110K ($0.04 diluted EPS) vs net loss $(87K) ($(0.04) per share) in Q3 2022.
- Q3 revenue $2.696M (+33% YoY); gross margin improved to 41.5% from 37.8%.
- Nine-month net profit $111K ($0.05 EPS) vs net loss $(433K) ($(0.18) EPS) in prior year.
- SpinDx THC saliva test beta expected early 2024, commercialization later 2024; R&D spending up 65%.
- Production backlog satisfied as supply chain constraints significantly relieved during Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323001538/0001079973-23-001538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323001538/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-001538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer